Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment

Дата публикации: 14-07-2026 00:00:00

This cohort study examines the absolute risk of progression to cognitive impairment and rates of cognitive decline per the blood-based biomarker plasma phosphorylated tau 217 (p-tau217) among cognitively unimpaired older adults.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	p-Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation	0	15.37	01-09-2024
2	La proteína p-tau217 en sangre, clave para predecir el riesgo de Alzheimer en personas sanas con décadas de antelación	0	9.6	15-07-2026
3	Simple blood test can forecast Alzheimer’s years before memory loss	0	7.43	23-02-2026
4	Simple blood test may predict risk of developing dementia up to 10 years before diagnosis	0	15.8	15-07-2026
5	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	9.23	15-07-2026
6	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
7	Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS	0	8.04	03-08-2026
8	Tau Oligomer–Containing Synapses Engulfed by Microglia and Astrocytes in Alzheimer Disease	0	7.6	01-11-2023
9	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
10	Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis	0	8.77	01-04-2024

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.88. Источник: archderm.jamanetwork.com.